FLT3 Inhib Generic AML Medication

Gilteritinib is an FLT3 inhibitor. It’s used to treat AML that keeps coming back or doesn’t respond to treatment in people who have FLT3 mutations. It works by stopping FLT3 kinase, which helps to keep leukemia cells from growing.

The tablets come as film-coated pills, and each one has 40 mg of the stuff. You’re supposed to take 120 mg of this stuff once a day. You’ll get 90 tablets in a bottle.

Gilteritinib is a big deal for treating AML when FLT3 mutations are involved. It’s a key player in the treatment plan.